| Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation S Ueshima, D Hira, R Fujii, Y Kimura, C Tomitsuka, T Yamane, Y Tabuchi, ... Pharmacogenetics and genomics 27 (9), 329-336, 2017 | 95 | 2017 |
| BCRP/ABCG2 and high-alert medications: Biochemical, pharmacokinetic, pharmacogenetic, and clinical implications D Hira, T Terada Biochemical pharmacology 147, 201-210, 2018 | 85 | 2018 |
| Assessment of sunitinib-induced toxicities and clinical outcomes based on therapeutic drug monitoring of sunitinib for patients with renal cell carcinoma S Noda, T Otsuji, M Baba, T Yoshida, S Kageyama, K Okamoto, Y Okada, ... Clinical genitourinary cancer 13 (4), 350-358, 2015 | 83 | 2015 |
| Gene silencing in a mouse lung metastasis model by an inhalable dry small interfering RNA powder prepared using the supercritical carbon dioxide technique T Okuda, D Kito, A Oiwa, M Fukushima, D Hira, H Okamoto Biological and Pharmaceutical Bulletin 36 (7), 1183-1191, 2013 | 68 | 2013 |
| Population pharmacokinetics and therapeutic efficacy of febuxostat in patients with severe renal impairment D Hira, Y Chisaki, S Noda, H Araki, T Uzu, H Maegawa, Y Yano, S Morita, ... Pharmacology 96 (1-2), 90-98, 2015 | 61 | 2015 |
| Intestinal and hepatic drug transporters: pharmacokinetic, pathophysiological, and pharmacogenetic roles T Terada, D Hira Journal of gastroenterology 50, 508-519, 2015 | 60 | 2015 |
| Systematic review of salivary versus blood concentrations of antituberculosis drugs and their potential for salivary therapeutic drug monitoring SHJ van den Elsen, LM Oostenbrink, SK Heysell, D Hira, DJ Touw, ... Therapeutic drug monitoring 40 (1), 17-37, 2018 | 50 | 2018 |
| Population pharmacokinetics and pharmacogenomics of apixaban in Japanese adult patients with atrial fibrillation S Ueshima, D Hira, Y Kimura, R Fujii, C Tomitsuka, T Yamane, Y Tabuchi, ... British journal of clinical pharmacology 84 (6), 1301-1312, 2018 | 46 | 2018 |
| Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices D Hira, H Koide, S Nakamura, T Okada, K Ishizeki, M Yamaguchi, ... PLoS One 13 (2), e0193082, 2018 | 44 | 2018 |
| Inhalable spray-freeze-dried powder with L-leucine that delivers particles independent of inspiratory flow pattern and inhalation device H Otake, T Okuda, D Hira, H Kojima, Y Shimada, H Okamoto Pharmaceutical research 33, 922-931, 2016 | 39 | 2016 |
| Exploratory investigation of target pazopanib concentration range for patients with renal cell carcinoma S Noda, T Yoshida, D Hira, R Murai, K Tomita, T Tsuru, S Kageyama, ... Clinical Genitourinary Cancer 17 (2), e306-e313, 2019 | 30 | 2019 |
| Pharmacokinetic interaction between sorafenib and prednisolone in a patient with hepatocellular carcinoma S Noda, M Shioya, D Hira, Y Fujiyama, S Morita, T Terada Cancer chemotherapy and pharmacology 72, 269-272, 2013 | 28 | 2013 |
| Problems of elderly patients on inhalation therapy: Difference in problem recognition between patients and medical professionals D Hira, Y Komase, S Koshiyama, T Oguma, T Hiramatsu, A Shiraki, ... Allergology International 65 (4), 444-449, 2016 | 26 | 2016 |
| Inhalation performance of physically mixed dry powders evaluated with a simple simulator for human inspiratory flow patterns D Hira, T Okuda, D Kito, K Ishizeki, T Okada, H Okamoto Pharmaceutical research 27, 2131-2140, 2010 | 22 | 2010 |
| Effect of Antibiotic Susceptibility and CYP3A4/5 and CYP2C19 Genotype on the Outcome of Vonoprazan-Containing Helicobacter pylori Eradication Therapy M Sugimoto, D Hira, M Murata, T Kawai, T Terada Antibiotics 9 (10), 645, 2020 | 21 | 2020 |
| Influence of peak inspiratory flow rates and pressure drops on inhalation performance of dry powder inhalers D Hira, T Okuda, M Ichihashi, A Mizutani, K Ishizeki, T Okada, H Okamoto Chemical and Pharmaceutical Bulletin 60 (3), 341-347, 2012 | 19 | 2012 |
| CYP3A4/5 genotype status and outcome of vonoprazan-containing Helicobacter pylori eradication therapy in Japan. M Sugimoto, H Ban, D Hira, T Kamiya, T Otsuka, O Inatomi, S Bamba, ... Alimentary Pharmacology & Therapeutics 45 (7), 2017 | 18 | 2017 |
| Comparison between clopidogrel and prasugrel associated with CYP2C19 genotypes in patients receiving percutaneous coronary intervention in a Japanese population Y Sawayama, T Yamamoto, Y Tomita, K Asada, N Yagi, M Fukuyama, ... Circulation Journal 84 (9), 1575-1581, 2020 | 15 | 2020 |
| Oral mucositis associated with anti-EGFR therapy in colorectal cancer: single institutional retrospective cohort study S Dote, S Itakura, K Kamei, D Hira, S Noda, Y Kobayashi, T Terada BMC cancer 18, 1-7, 2018 | 15 | 2018 |
| Results of a nationwide survey of Japanese pharmacists regarding the application of pharmacogenomic testing in precision medicine D Tsuji, Y Saito, T Mushiroda, M Miura, D Hira, T Terada Journal of clinical pharmacy and therapeutics 46 (3), 649-657, 2021 | 13 | 2021 |
